MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Safety of levodopa-carbidopa intestinal gel treatment in advanced Parkinson’s disease patients receiving ≥ 2000 mg daily dose of levodopa

    C. Zadikoff, J. Boyd, S. Dubow, L. Bergmann, W. Robieson, H. Ijacu, J. Benesh (Chicago, IL, USA)

    Objective: To examine the safety of levodopa-carbidopa intestinal gel treatment (LCIG, carbidopa-levodopa enteral suspension in the US) in advanced Parkinson’s disease (PD) patients that received…
  • 2017 International Congress

    Functional role of the cerebellum in Parkinson’s disease : a PET-Study

    A. Riou, F. Le Jeune, J.-F. Houvenaghel, S. Drapier, M. Vérin, G. Robert (RENNES, France)

    Objective: The aim of this study is to confirm the hypothesis of a functional involvement of the cerebellum in Parkinson's disease according to a tri-compartmental…
  • 2017 International Congress

    Writing training enhances neural connectivity in Parkinson’s patients with micrographia

    E. Nackaerts, J. Michely, E. Heremans, S. Swinnen, B. Smits-Engelsmans, W. Vandenberghe, C. Grefkes, A. Nieuwboer (Leuven, Belgium)

    Objective: To study network interactions of patients with Parkinson’s disease (PD) and healthy controls (CT) during handwriting with and without external visual cues and to…
  • 2017 International Congress

    Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease

    M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We evaluated the signal intensity of the cerebral gyri (CG) on phase difference enhanced imaging (PADRE) for the patients with corticobasal degeneration (CBD), progressive…
  • 2017 International Congress

    Prospective Analysis of Morphological Markers of Development of Impulsive Compulsive Behaviors in De Novo Parkinson’s Disease

    L. Ricciardi, C. Lambert, R. De Micco, F. Morgante, M. Edwards (London, United Kingdom)

    Objective: Aim of this study was to determine whether structural imaging features present at disease onset or over disease course predict the development of ICB…
  • 2017 International Congress

    Body mass index, change in body mass index and risk of Parkinson`s disease

    J. Lee, J.H. Kim, J.H. Cho, G.S. Kim, J.H. Lee, P.H. Lee, Y.H. Sohn (Goyang-shi, Republic of Korea)

    Objective:  Our aim is to show the association between BMI and risk of PD and to evaluate how change in BMI is associated with occurrence…
  • 2017 International Congress

    Do motor symptoms influence on malnutrition in Parkinson`s disease patients?

    S. Tomic, V. Pekic, Z. Popijac, T. Pucic, M. Petek, T. Gilman Kuric (Osijek, Croatia)

    Objective: The aim of this study was to determine the prevalence of malnutrition and to analyze influence of age, sex, disease duration and motor symptoms…
  • 2017 International Congress

    Gender differences in motor and non-motor features across the Parkinson’s disease spectrum

    T. Dunne, G. Stebbins, C. Goetz, S. Luo, J. Goldman (Chicago, IL, USA)

    Objective: To examine how gender differences influence the motor and non-motor features across the Parkinson’s disease (PD) spectrum. Background: There is evidence of male predominance…
  • 2017 International Congress

    Impact of Duopa™ on Non-Motor Symptoms of Parkinson’s Patients with Deep Brain Stimulation

    A. Wadhwa, R. Govindarajan, I. Asher (Columbia, MO, USA)

    Objective: To report the role and impact of Duopa on non-motor Parkinsonian symptoms in patients with deep brain stimulation within a month from starting therapy.…
  • 2017 International Congress

    Serum Mir-30c as a Potential Biomarker to Discriminate MSA from PD Patients: A Pilot Study.

    A. Vallelunga, M. Sessa, D. Giovanna, M. Picillo, P. Barone, M.T. Pellecchia (Salerno, Italy)

    Objective: In this pilot study we evaluated  serum mir-30c levels in MSA and  PD patients, to assess if mir-30c can be useful to distinguish these…
  • « Previous Page
  • 1
  • …
  • 322
  • 323
  • 324
  • 325
  • 326
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley